Division of Hematology and Oncology

Specializing in myeloma, amyloidosis and other plasma cell disorders, hematologist and medical oncologist Muhamed Baljević, MD, recently joined Vanderbilt University Medical Center.

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs.

Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles.

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.

The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.